Alex Zhavoronkov
FounderFounder & CEO at Insilico Medicine Β· Chief Longevity Advisor at Deep Longevity
Cambridge, Massachusetts, United States
Founder & CEO at Insilico Medicine
Intro paths
β
In turn, Alex can intro founders to Insilico Medicine's investors below.
Insilico Medicine's investors Β· 16
B Capital GroupManhattan Beach Β· $10M β $50M checks Β· since 2019B4 Capital$10M β $50M checks Β· since 2019Baidu VenturesBeijing Β· $1.4M β $145M checks Β· since 2019BOLD LongevityBoston Β· since 2019Eight Roads VenturesMumbai Β· $5M β $30M checks Β· since 2019F-Prime CapitalCambridge Β· $3M β $10M checks Β· since 2019Gestio CapitalLondon Β· since 2019Lake Bleu CapitalHong Kong Β· since 2019LAVHong Kong Β· $5M β $15M checks Β· since 2019Lilly Asia VenturesHong Kong Β· since 2019LongeVCWashington D.C. Β· since 2019OrbiMedNew York Β· $1M β $75M checks Β· since 2019Prosperity7 VenturesDhahran Β· since 2019Qiming Venture PartnersBeijing Β· $5M β $134M checks Β· since 2019Sinovation VenturesBeijing Β· $1M β $110M checks Β· since 2019Warburg PincusNew York Β· since 2019
Co-founders at Insilico Medicine
AZ
Alex ZavoronkovDirector
AA
Alex AliperPresident
Chief Longevity Advisor at Deep Longevity
Intro paths
β
In turn, Alex can intro founders to Deep Longevity's investors below.
Deep Longevity's investors Β· 3
Experience
- Insilico MedicineChief Executive Officer and Chief Business Officercurrent2025 β presentBoston, Massachusetts, United States
- Insilico MedicineFounder and CEOcurrent2014 β presentCambridge, Massachusetts, United States
- HautAI OUScientific Advisorcurrent2017 β present
- Deep LongevityChief Longevity Officer2020 β 2024
- Deep LongevityFounder and CEO2020
- The International Aging Research Portfolio (IARP) - - NON PROFITFounder2008 β 2018
- Biogerontology Research FoundationAdvisor2008 β 2018London, United Kingdom
- Moscow Institute of Physics and Technology (State University) - MIPT, PhystechInternational Adjunct Professor2013 β 2015
- NeuroGChief Technology Officer2009 β 2014Hong Kong
- Center for Pediatric Hematology, Oncology and ImmunologyHead of the Regenerative Medicine Laboratory2012 β 2014
- Center for Pediatric Hematology, Oncology and ImmunologyHead of the Bioinformatics Laboratory2011 β 2013
- SequenomConsultant2009 β 2011
- Colby Pharmaceutical CompanyDirector, BD2008 β 2009
- GTCbioDirector, BD2007 β 2008monrovia, california
- ATI TechnologiesDirector2004 β 2006
- ATI TechnologiesRegional Manager, Eastern Europe2003 β 2005
- ATI Technologies, Inc, Markham, CanadaManager2002 β 2003
- PMC-Sierra, IncProduct Marketing Engineer2001 β 2002British Columbia, Canada
Skills & more
Biomedical EngineeringBiotechnologyScienceDiagnosticsEUEastern EuropePharmaceuticalsLife SciencesBloggingRisk ManagementCredit RiskGenetics
+12 more
Tissue EngineeringRegenerative MedicineRetirement SolutionsRetirement Plan ConsultingLaser PhysicsRFIDPrenatalEconomic ModelingChemistryAgingGerontologybiogerontologyLanguages English Β· German Β· Russian
From Alex's professional profile.
Frequently asked questions
- Who is Alex Zhavoronkov?
- Founder & CEO at Insilico Medicine
- Where does Alex Zhavoronkov work?
- Alex Zhavoronkov is Chief Longevity Advisor of Deep Longevity and Founder & CEO at Insilico Medicine.
- What companies did Alex Zhavoronkov found?
- Alex Zhavoronkov founded Deep Longevity, Insilico Medicine.
- Where did Alex Zhavoronkov go to school?
- Alex Zhavoronkov studied at Queen's University (Bachelor of Commerce (Honors), Finance, Management of Information Systems); Lomonosov Moscow State University (MSU) (PhD, Physics); The Johns Hopkins University (Master of Science, Biotechnology).
Same school
Also attended Queen's University408
Steph TryphonasCo-founder of Collaborative RoboticsHark AhluwaliaAssociate at RevolutionSydney SloanChief Marketing Officer at Scale Venture PartnersZeya YangInvestor at IVP (Institutional Venture Partners)Curtis UrbanowiczInvestment at Makers FundSanjiv KalevarPartner at Mucker Capital
+ 402 more
Also attended Lomonosov Moscow State University (MSU)84
Manuk HergnyanCo-Founder & Managing Partner at Granatus VenturesFredric PetitPartner, Head of Materials & Packaging at Emerald Technology Ventures AgGunner HardyAssociate at BOLD LongevityLidia SutorminaChief Communications Officer at C4 VenturesVasily FedorinChief Operating Officer at 4BIO CapitalDima KuzminManaging Partner at 4BIO Capital
+ 78 more
Also attended The Johns Hopkins University427
Dave JohnsonCo-founder & CEO of Dash BioNicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Wes NicholsPartner at March Capital PartnersDemi ObayomiPrincipal at Sapphire VenturesJun JeonInvestor at Khosla VenturesNicole FraenkelInvestor at Khosla Ventures
+ 421 more
Also attended Canadian Securities Institute37
Alex McIsaacGeneral Partner at Inovia CapitalTy WirvinAssociate Vice President at WestCapKulwant DuhraDirector of Investor Services & Experience at The 51 VenturesTony RautavaAssociate, Pender Ventures at Pender Growth FundChris RobertsonPartner at TELUS VenturesEnio LazzerCOO and CFO at Espresso Capital
+ 31 more
Shared employers
Also worked at Insilico Medicine4
Also worked at Biogerontology Research Foundation1
Also worked at Sequenom7
Jay B. LichterManaging Partner at Avalon BioVenturesNola MastersonVenture Fund Partner at PortfoliaBill WelchVenture Partner at Illuminate VenturesHyuk-Jeen SuhGeneral Partner at SkyRiver VenturesCharlie RodiFounder and CSO at RhoDxMichael TolentinoExecutive Officer, Director at Aviceda Therapeutics
+ 1 more
Also worked at ATI Technologies96
Ray SchuderSr. Investment Director at Samsung Catalyst FundBrian FrankPartner at Permanent Capital VenturesChristina NeoAssociate at Asia PartnersWael NafeeGeneral Partner at RAED VenturesDaisy CaiGeneral Partner at B CapitalEva LauFounding and General Partner at Inovia Capital
+ 90 more

.jpeg)



















































